Find your next paid study

Metastatic Bladder Urothelial CarcinomaMetastatic Malignant Solid NeoplasmStage IV Bladder Cancer AJCC v8+1 more

Mayo ClinicNCT07612007

Phase 2

A Phase II Trial to Evaluate Pemetrexed Response in Relation to Tumor Alterations of Gene Status in Patients With Previously Treated Metastatic Urothelial Carcinoma and Other Solid Tumors

This phase II trial tests how well pemetrexed works in treating patients with urothelial bladder cancer and other solid tumors that have spread from where they…

Northwestern UniversityNCT06630416

Phase 1

A Seamless Phase 1/2 Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Autologous Logic-gated Tmod™ CAR T Products, in Heterozygous HLA-A02 Adults With Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors That Express MSLN and Have Lost HLA-A02 Expression

The goal of this study is to test autologous logic-gated Tmod™ CAR T-cell products in subjects with solid tumors including colorectal cancer (CRC), pancreatic …

Solid Tumor, AdultColorectal CancerNSCLC+17 more

A2 Biotherapeutics Inc.NCT06051695

~$10 – $8,750

Phase 4

Knight Cancer Institute Study of Histology-Agnostic Immunotherapy With Focus on Timing: - Knight SHIFT - A Prospective, Multi-Histology Pragmatic Study

This phase IV trial is evaluating whether morning versus afternoon administration of standard of care immunotherapy impacts its effectiveness in treating patie…

Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more

Breast CarcinomaEsophageal CarcinomaGenitourinary System Carcinoma+6 more

~$10 – $7,500

Data Collection to Assess Acute and Late Normal Tissue Sequelae in Proton Therapy for Adults

This study collects information on the side effects of proton therapy and detailed information on the proton therapy treatment plan itself. This may help resea…

M.D. Anderson Cancer CenterNCT00991094

~$10 – $750

Lung CarcinomaLung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the Lung+3 more

A Single-Arm Phase II Study of Personalized Dose Guidance for Stereotactic Body Radiotherapy (SBRT) in Patients With Lung Tumors

This phase II trial tests the effectiveness and safety of artificial intelligence (AI) to determine dose recommendation during stereotactic body radiation ther…

Northwestern UniversityNCT05802186

Head and Neck CancerSurvivorshipCaregiver Burden+1 more

A Randomized Controlled Trial to Evaluate the Survivorship Needs Assessment Planning (SNAP) Tool for Head and Neck Cancer Survivor-Caregiver Dyads

In this randomized behavioral intervention, head and neck cancer (HNC) survivors and their caregivers (N=176 HNC survivor-caregiver dyads) will be randomized t…

Medical University of South CarolinaNCT05811936

Phase 2

A Phase II Study of Pembrolizumab in Combination With Circulating Tumor DNA Response-Adaptive Pulsed Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: The SINERGY Trial (Squamous Cell Carcinoma of Head and Neck Response-Guided Therapy)

By doing this study, the research team would like to learn if using a blood test that measures the amount of tumor DNA in blood can help guide how to use chemo…

Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Neoplasms+2 more

University of ChicagoNCT05420948

Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Solid Neoplasm

Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery: A Phase II Study

This phase II trial studies the neurological function in patients with multiple brain metastases undergoing stereotactic radiosurgery (SRS) or stereotactic bod…

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityNCT03184038

Hematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmCancer+1 more

ACES: Advancing Capacity to Integrate Exercise Into the Care of Older Cancer Survivors

The study will assess the feasibility and preliminary efficacy of live, online supervised group functional resistance training in older cancer survivors who ma…

OHSU Knight Cancer InstituteNCT07606313

~$10 – $7,500

Phase 1

Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

The purpose of this research is to see if adding blood-based tests and symptom review to standard-of-care pancreatic cancer screening procedures can identify c…

Pancreatic CancerPancreatic Ductal AdenocarcinomaPDAC+2 more

Dana-Farber Cancer InstituteNCT06122896

~$10 – $7,500

Key Elements for Standardized Reporting in Prostate Cancer Management: An Expert Delphi Consensus Study

This study formulates consensus agreement on clinical key elements related to prostate cancer care that are critical for standardization and global reported us…

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm